0000950156-11-000044.txt : 20110512 0000950156-11-000044.hdr.sgml : 20110512 20110325160301 ACCESSION NUMBER: 0000950156-11-000044 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IGI LABORATORIES, INC CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 6096971441 MAIL ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IGI INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 CORRESP 1 filename1.htm Converted by EDGARwiz

IGI Laboratories, Inc.

105 Lincoln Avenue

Buena, New Jersey 08310


March 25, 2011


Via EDGAR


Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549


Attention:

Johnny Gharib, Division of Corporation Finance

Jeffrey Riedler, Assistant Director


Re:

IGI Laboratories, Inc.

Registration Statement on Form S-3

Registration No. 333-171446


Dear Sir or Madam:


IGI Laboratories, Inc., a Delaware corporation (the “Company”), hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the effective date of the Company’s Registration Statement on Form S-3, Registration No. 333-171446 (the “Registration Statement”), be accelerated so that the Company’s Registration Statement will become effective, at 4:15 p.m. Eastern Standard Time on Monday, March 28, 2011, or as soon thereafter as practicable.


In connection with this acceleration request, the Company acknowledges that:


•

should the U.S. Securities and Exchange Commission (“Commission”), or its Staff (“Staff”) acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the filing;


•

the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the Registration Statement’s disclosures; and


•

the Company will not assert the declaration of the Registration Statement’s effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.


 

Very truly yours,

 

IGI Laboratories, Inc.

 

 

 

By:

/s/ Charles Moore

 

 

Charles Moore

 

 

President and Chief Executive Officer